Freedom to Operate: Evaluating Current Strategies to Avoid Future Findings of Infringement

May 16, 2019 2:15pm

Heather Boussios
Assistant General Counsel – IP
Aptevo Therapeutics (Seattle, WA)

Amy Fix
Shareholder
Brinks Gilson & Lione

Asha Nadipuram
Patent Attorney
Novartis Institutes for BioMedical (Cambridge, MA)

  • Assessing the current regulatory landscape for FTO analysis
  • Analyzing when during R&D third party patents discovered through FTO should be of concern
  • Understanding how extensive search sequencing should be during FTO
  • Seeking out the current capabilities of FTO relating to biologic patents
  • Evaluating the most effective process for FTO analysis
    • Should it be in the hands of inhouse or outside counsel?